相关实验视频

Updated: May 22, 2026

Synergetic Use of Neural Precursor Cells and Self-assembling Peptides in Experimental Cervical Spinal Cord Injury

Synergetic Use of Neural Precursor Cells and Self-assembling Peptides in Experimental Cervical Spinal Cord Injury

Published on: February 23, 2015

用于脊髓修复的相适应金属离子供应与一个Mg-Zn合并的化学微球

Xiangyu Liu¹, Biao Ma², Sihan Hu³

¹Institute of Translational Medicine, Medical College, Yangzhou University, Yangzhou, China; Department of Orthopedics, Affiliated Hospital of Yangzhou University, Yangzhou, China; Jiangsu Key Laboratory of Integrated Traditional Chinese and Western Medicine for Prevention and Treatment of Senile Diseases, Yangzhou University, Yangzhou, 225001, China.

|March 19, 2025

概括

这项研究开发了一种用于脊髓损伤 (SCI) 修复的双金属离子水凝微球. 早期的 (Mg2+) 释放减少了炎症,而晚些时候的 (Zn2+) 释放促进了神经再生和恢复.

科学领域:

生物材料科学生物材料科学
神经科学是一个神经科学.
再生医学是一种再生医学.

背景情况:

脊髓损伤 (SCI) 涉及金属离子度的动态变化.
战略性,相位特定的金属离子输送可以帮助脊髓修复和减轻病理损伤.

研究的目的:

设计和评估用于控制,相适应的 (Mg2+) 和 (Zn2+) 离子输送的嵌合式水凝微球.
研究这种双金属离子系统在促进脊髓损伤后修复方面的治疗潜力.

主要方法:

一个核心外仿真水凝微球的制造:Mg2+交叉连接的甲基烯酸凝 (外) 和Zn2+加载的多酸 (PLGA) (核心).
在体外和体内评估微球的离子释放概况和脊髓损伤模型中的治疗疗效.

主要成果:

早期的Mg2+释放通过调节巨细胞极化和减少促炎细胞因子来抑制炎症,从而减少痕形成.
随后的Zn2+释放促进了神经细胞的增殖,再生和各种神经元类型的激活,导致显著的行为恢复.
嵌合体微球有效地控制了炎症反应,并促进了神经再生.

结论:

金属离子在脊髓损伤修复的不同阶段发挥着关键的,不同的作用.
可注射的嵌合式水凝微球通过克服炎症和再生之间的时间冲突,为SCI提供了一个有希望的治疗策略.

关键词:

核心-外结构核心-外结构可以注射的嵌合体微球.金属离子是金属离子.脊髓损伤导致的脊髓损伤

更多相关视频

Experimental Strategies to Bridge Large Tissue Gaps in the Injured Spinal Cord after Acute and Chronic Lesion

Experimental Strategies to Bridge Large Tissue Gaps in the Injured Spinal Cord after Acute and Chronic Lesion

Published on: April 5, 2016

Transplantation of Schwann Cells Inside PVDF-TrFE Conduits to Bridge Transected Rat Spinal Cord Stumps to Promote Axon Regeneration Across the Gap

Transplantation of Schwann Cells Inside PVDF-TrFE Conduits to Bridge Transected Rat Spinal Cord Stumps to Promote Axon Regeneration Across the Gap

Published on: November 3, 2017

相关概念视频

Pulmonary Tuberculosis I

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

Pulmonary Tuberculosis II

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

Pulmonary Tuberculosis III

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:

Pulmonary Tuberculosis IV

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...